Conference Coverage
Conference Coverage
IDWEEK: Antibiotic ‘time-out’ cut vancomycin use
A self-directed antibiotic time-out performed 72-96 hours into treatment was tied to increases in appropriate discontinuations of vancomycin.
Conference Coverage
Some household pets found to be colonized with S. aureus
In households of children with methicillin-resistant Staphylococcus aureus (MRSA) infection, pet dogs and cats were often colonized with S. aureus...
Conference Coverage
HIV testing low among patients admitted for pneumonia
Only 39% of patients hospitalized for pneumonia underwent HIV testing, even though federal recommendations for universal HIV screening in all...
Conference Coverage
VIDEO: Antibiotic stewardship program impacted C. diff. rates in kids
Following implementation of an antibiotic stewardship program, hospitalized children were more than three times less likely to develop Clostridium...
Conference Coverage
VIDEO: Tranexamic acid didn’t increase postop infections
Conference Coverage
SSI risk after cesarean is nearly double for Medicaid patients
The association remained even after researchers accounted for several demographic and clinical variables, Dr. Sarah Yi said in an interview at an...
Conference Coverage
Widespread rotavirus vaccination caused plunge in pediatric hospitalizations
Rhode Island’s universal vaccine policy led to widespread vaccination against rotavirus, steep drops in pediatric hospitalizations for...
Conference Coverage
Parasitic infection emerging in the Southwestern U.S.
Key clinical point: Lesions containing a zoonotic parasite known as Onchocerca lupi are appearing in humans who reside in the Southwestern United...
Conference Coverage
Hospitals report inadequate duodenoscope reprocessing practices
Less than a third of hospitals reprocessed duodenoscopes adequately to prevent potential transmission of carbapenem-resistant Enterobacteriaceae (...
Conference Coverage
Big declines seen in aspergillosis mortality
The outlook for patients with aspergillosis-related hospitalization improved greatly during a recent 10-year period.
Conference Coverage
Old drug is new treatment for chronic prostatitis
Oral fosfomycin achieved an 85% cure rate in multidrug-resistant chronic prostatitis.